Lymna-DF-amide 4 is a neuropeptide characterized in the pond snail Lymnaea and is associated with feeding and locomotor regulation studies. Its RFamide-like C-terminus supports receptor-binding investigations in gastropod systems. Researchers use it to analyze peptide-induced neuronal activity and synaptic modulation. The peptide aids comparative analysis of invertebrate neuropeptide families.
CAT No: L14004
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More